James Williamson

BAROnova, Inc. operates as a clinical-stage medical-device company. It develops nonsurgical, nonpharmacologic devices. The firm's TransPyloric Shuttle device enables the patient' stomach to fill up faster, stay full longer, and potentially delay gastric emptying. The company was founded by Hugh Narciso in 2006 and is headquartered in Goleta, CA.

Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA.

Delos Capital Fund LP is a health care focused fund invests in companies located in Greater China and US. The fund targets companies operating in the fields of therapeutics and medical technology. It provides financing in the form of later stage capital, buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital. It also makes investments in public listed companies.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Goldman Sachs Japan Co., Ltd. (GSJCL) is the Japan-based broker-dealer subsidiary of Goldman Sachs (Japan) Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm originated in 1974 and was formally founded in 1983. Headquartered in Tokyo, GSJCL offers Internet-based transaction services covering equity, debt, commodities and derivatives to a substantial and diversified client base, which includes corporations, financial institutions, governments and high net worth individuals.

Part of Davis Polk & Wardwell LLP, Davis Polk & Wardwell (Hong Kong) is a company based in Hong Kong, Hong Kong.

President International Development Corporation is an investment holding company of the Uni-President Group (UPG). The company engages in the management of investments of UPG. It also provides financial consulting services to the subsidiaries of UPG. Its investment scope stretches across the industries of biomedicine, real estate, optoelectronics, consumer goods, financial services, energy, textile, petrochemical, as well as telecommunications. Moreover, it has financial investments in domestic and foreign capital markets. The company was founded on October 8, 1997 and is headquartered in Taipei, Taiwan.

Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany.

Atia Vision, Inc. provides medical device services. The company was founded in 2012 and is headquartered in Campbell, CA.

Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong.

Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA.

Imperative Care, Inc. is a healthcare technology company, which provides solutions to solve problems in stroke. It focuses on medical technology designed to expedite and improve the effectiveness of treatment, giving patients a chance for optimal recovery. The company is headquartered in Campbell, CA.

Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA.

HeMo Bioengineering Ltd. operates as a medical device company. Its portfolio of neuro-interventional medical devices covers all of the ischemic stroke, hemorrhagic stroke and neuro access fields. The company was founded in June 21, 2017 and is headquartered in Weihai, China.